{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:50:37Z","timestamp":1792497037156,"version":"4.5.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurosci"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1038\/nrn2297","type":"journal-article","created":{"date-parts":[[2007,12,12]],"date-time":"2007-12-12T04:40:31Z","timestamp":1197434431000},"page":"46-56","source":"Crossref","is-referenced-by-count":6485,"title":["From inflammation to sickness and depression: when the immune system subjugates the brain"],"prefix":"10.1038","volume":"9","author":[{"given":"Robert","family":"Dantzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory G.","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith W.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrn2297_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","volume":"21","author":"R Dantzer","year":"2007","unstructured":"Dantzer, R. & Kelley, K. W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 21, 153\u2013160 (2007).","journal-title":"Brain Behav. Immun."},{"key":"BFnrn2297_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","volume":"12","author":"BL Hart","year":"1988","unstructured":"Hart, B. L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 12, 123\u2013137 (1988). The original description of sickness behaviour, its relationship with fever and adaptive value.","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BFnrn2297_CR3","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/0024-3205(89)90345-7","volume":"44","author":"R Dantzer","year":"1989","unstructured":"Dantzer, R. & Kelley, K. W. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci. 44, 1995\u20132008 (1989).","journal-title":"Life Sci."},{"key":"BFnrn2297_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1006\/brbi.2000.0613","volume":"15","author":"R Dantzer","year":"2001","unstructured":"Dantzer, R. Cytokine-induced sickness behavior: where do we stand? Brain Behav. Immun. 15, 7\u201324 (2001).","journal-title":"Brain Behav. Immun."},{"key":"BFnrn2297_CR5","volume-title":"Depression and Physical Illness","author":"A Steptoe","year":"2007","unstructured":"Steptoe, A. (ed.) Depression and Physical Illness (Cambridge University Press, Cambridge, 2007)."},{"key":"BFnrn2297_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.it.2006.11.004","volume":"28","author":"I Galea","year":"2007","unstructured":"Galea, I., Bechmann, I. & Perry, V. H. What is immune privilege (not)? Trends Immunol. 28, 12\u201318 (2007). A review of how the brain immune response differs from that in other organs.","journal-title":"Trends Immunol."},{"key":"BFnrn2297_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/B978-012088576-3\/50018-6","volume-title":"Psychoneuroimmunology","author":"R Dantzer","year":"2007","unstructured":"Dantzer, R. in Psychoneuroimmunology (ed. Ader, R.) 271\u2013280 (Elsevier, Amsterdam, 2007)."},{"issue":"III","key":"BFnrn2297_CR8","first-page":"499","volume":"317","author":"RM Bluthe","year":"1994","unstructured":"Bluthe, R. M. et al. Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C. R. Acad. Sci. III 317, 499\u2013503 (1994). The first demonstration that section of the vagus nerves blocks immune-to-brain communication and abrogates lipopolysacccharide-induced sickness behaviour without compromising the peripheral immune response.","journal-title":"C. R. Acad. Sci."},{"key":"BFnrn2297_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0006-8993(94)91742-6","volume":"639","author":"LR Watkins","year":"1994","unstructured":"Watkins, L. R. et al. Neurocircuitry of illness-induced hyperalgesia. Brain Res. 639, 283\u2013299 (1994).","journal-title":"Brain Res."},{"key":"BFnrn2297_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0165-5728(01)00270-3","volume":"115","author":"HE Romeo","year":"2001","unstructured":"Romeo, H. E., Tio, D. L., Rahman, S. U., Chiappelli, F. & Taylor, A. N. The glossopharyngeal nerve as a novel pathway in immune-to-brain communication: relevance to neuroimmune surveillance of the oral cavity. J. Neuroimmunol. 115, 91\u2013100 (2001).","journal-title":"J. Neuroimmunol."},{"key":"BFnrn2297_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0306-4522(97)00350-3","volume":"83","author":"N Quan","year":"1998","unstructured":"Quan, N., Whiteside, M. & Herkenham, M. Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 83, 281\u2013293 (1998).","journal-title":"Neuroscience"},{"key":"BFnrn2297_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.mp.4000813","volume":"5","author":"L Vitkovic","year":"2000","unstructured":"Vitkovic, L. et al. Cytokine signals propagate through the brain. Mol. Psychiatry 5, 604\u2013615 (2000).","journal-title":"Mol. Psychiatry"},{"key":"BFnrn2297_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ncl.2006.03.009","volume":"24","author":"WA Banks","year":"2006","unstructured":"Banks, W. A. The blood-brain barrier in psychoneuroimmunology. Neurol. Clin. 24, 413\u2013419 (2006).","journal-title":"Neurol. Clin."},{"key":"BFnrn2297_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/cne.20052","volume":"472","author":"JP Konsman","year":"2004","unstructured":"Konsman, J. P., Vigues, S., Mackerlova, L., Bristow, A. & Blomqvist, A. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J. Comp. Neurol. 472, 113\u2013129 (2004).","journal-title":"J. Comp. Neurol."},{"key":"BFnrn2297_CR15","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1523\/JNEUROSCI.22-13-05606.2002","volume":"22","author":"JC Schiltz","year":"2002","unstructured":"Schiltz, J. C. & Sawchenko, P. E. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J. Neurosci. 22, 5606\u20135618 (2002).","journal-title":"J. Neurosci."},{"key":"BFnrn2297_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S1566-0702(00)00220-4","volume":"85","author":"R Dantzer","year":"2000","unstructured":"Dantzer, R., Konsman, J. P., Bluthe, R. M. & Kelley, K. W. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton. Neurosci. 85, 60\u201365 (2000).","journal-title":"Auton. Neurosci."},{"key":"BFnrn2297_CR17","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1523\/JNEUROSCI.22-12-05091.2002","volume":"22","author":"TM Reyes","year":"2002","unstructured":"Reyes, T. M. & Sawchenko, P. E. Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia. J. Neurosci. 22, 5091\u20135099 (2002).","journal-title":"J. Neurosci."},{"key":"BFnrn2297_CR18","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1523\/JNEUROSCI.14-02-00897.1994","volume":"14","author":"A Ericsson","year":"1994","unstructured":"Ericsson, A., Kovacs, K. J. & Sawchenko, P. E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 14, 897\u2013913 (1994).","journal-title":"J. Neurosci."},{"key":"BFnrn2297_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1359-6101(97)00023-3","volume":"8","author":"CA Dinarello","year":"1997","unstructured":"Dinarello, C. A. Interleukin-1. Cytokine Growth Factor Rev. 8, 253\u2013265 (1997).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnrn2297_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0165-5728(02)00022-X","volume":"125","author":"P Parnet","year":"2002","unstructured":"Parnet, P., Kelley, K. W., Bluthe, R. M. & Dantzer, R. Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior. J. Neuroimmunol. 125, 5\u201314 (2002).","journal-title":"J. Neuroimmunol."},{"key":"BFnrn2297_CR21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0006-8993(92)91588-6","volume":"588","author":"AM van Dam","year":"1992","unstructured":"van Dam, A. M., Brouns, M., Louisse, S. & Berkenbosch, F. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Res. 588, 291\u2013296 (1992). The first demonstration that peripherally administered lipopolysaccharide induces the expression of IL-1\u03b2 in the brain.","journal-title":"Brain Res."},{"key":"BFnrn2297_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0169-328X(94)90197-X","volume":"27","author":"S Laye","year":"1994","unstructured":"Laye, S., Parnet, P., Goujon, E. & Dantzer, R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res. Mol. Brain Res. 27, 157\u2013162 (1994).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"BFnrn2297_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0165-5728(98)00193-3","volume":"93","author":"N Quan","year":"1999","unstructured":"Quan, N., Stern, E. L., Whiteside, M. B. & Herkenham, M. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J. Neuroimmunol. 93, 72\u201380 (1999).","journal-title":"J. Neuroimmunol."},{"key":"BFnrn2297_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0006-8993(93)90090-A","volume":"624","author":"S Gatti","year":"1993","unstructured":"Gatti, S. & Bartfai, T. Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res. 624, 291\u2013294 (1993).","journal-title":"Brain Res."},{"key":"BFnrn2297_CR25","doi-asserted-by":"publisher","first-page":"11393","DOI":"10.1073\/pnas.91.24.11393","volume":"91","author":"CD Breder","year":"1994","unstructured":"Breder, C. D. et al. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc. Natl Acad. Sci. USA 91, 11393\u201311397 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2297_CR26","doi-asserted-by":"publisher","first-page":"R1344","DOI":"10.1152\/ajpregu.00141.2006","volume":"291","author":"MD Carmichael","year":"2006","unstructured":"Carmichael, M. D. et al. Role of brain IL-1beta on fatigue after exercise-induced muscle damage. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R1344\u20131348 (2006).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrn2297_CR27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/85507","volume":"7","author":"S Ohdo","year":"2001","unstructured":"Ohdo, S., Koyanagi, S., Suyama, H., Higuchi, S. & Aramaki, H. Changing the dosing schedule minimizes the disruptive effects of interferon on clock function. Nature Med. 7, 356\u2013360 (2001).","journal-title":"Nature Med."},{"key":"BFnrn2297_CR28","doi-asserted-by":"crossref","unstructured":"Cavadini, G. et al. TNF-{alpha} suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc. Natl Acad. Sci. USA (2007).","DOI":"10.1073\/pnas.0701466104"},{"key":"BFnrn2297_CR29","doi-asserted-by":"publisher","first-page":"10709","DOI":"10.1523\/JNEUROSCI.3376-06.2006","volume":"26","author":"NL Sparkman","year":"2006","unstructured":"Sparkman, N. L. et al. Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J. Neurosci. 26, 10709\u201310716 (2006).","journal-title":"J. Neurosci."},{"key":"BFnrn2297_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0169-328X(00)00042-5","volume":"77","author":"JR Heyen","year":"2000","unstructured":"Heyen, J. R., Ye, S., Finck, B. N. & Johnson, R. W. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain Res. Mol. Brain Res. 77, 138\u2013147 (2000).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"BFnrn2297_CR31","unstructured":"Strle, K. et al. Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGFI in myoblasts. J. Neuroimmunol. (in the press)."},{"key":"BFnrn2297_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0306-4530(98)00077-8","volume":"24","author":"RM Bluthe","year":"1999","unstructured":"Bluthe, R. M. et al. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology 24, 301\u2013311 (1999).","journal-title":"Psychoneuroendocrinology"},{"key":"BFnrn2297_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00001756-199902050-00015","volume":"10","author":"R Dantzer","year":"1999","unstructured":"Dantzer, R., Gheusi, G., Johnson, R. W. & Kelley, K. W. Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice. Neuroreport 10, 289\u2013292 (1999).","journal-title":"Neuroreport"},{"key":"BFnrn2297_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbi.2005.02.003","volume":"20","author":"RM Bluthe","year":"2006","unstructured":"Bluthe, R. M., Kelley, K. W. & Dantzer, R. Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice. Brain Behav. Immun. 20, 57\u201363 (2006).","journal-title":"Brain Behav. Immun."},{"key":"BFnrn2297_CR35","first-page":"R81","volume":"276","author":"LR Leon","year":"1999","unstructured":"Leon, L. R., Kozak, W., Rudolph, K. & Kluger, M. J. An antipyretic role for interleukin-10 in LPS fever in mice. Am. J. Physiol. 276, R81\u201389 (1999).","journal-title":"Am. J. Physiol."},{"key":"BFnrn2297_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0165-5728(98)00217-3","volume":"93","author":"SM Ye","year":"1999","unstructured":"Ye, S. M. & Johnson, R. W. Increased interleukin-6 expression by microglia from brain of aged mice. J. Neuroimmunol. 93, 139\u2013148 (1999).","journal-title":"J. Neuroimmunol."},{"key":"BFnrn2297_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000049025","volume":"9","author":"SM Ye","year":"2001","unstructured":"Ye, S. M. & Johnson, R. W. An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice. Neuroimmunomodulation 9, 183\u2013192 (2001).","journal-title":"Neuroimmunomodulation"},{"key":"BFnrn2297_CR38","doi-asserted-by":"crossref","unstructured":"Huang, Y., Henry, C. J., Dantzer, R., Johnson, R. W. & Godbout, J. P. Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol. Aging (2007).","DOI":"10.1016\/j.neurobiolaging.2007.04.012"},{"key":"BFnrn2297_CR39","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.4049\/jimmunol.174.8.4991","volume":"174","author":"JC O'Connor","year":"2005","unstructured":"O'Connor, J. C. et al. IL-1beta-mediated innate immunity is amplified in the db\/db mouse model of type 2 diabetes. J. Immunol. 174, 4991\u20134997 (2005).","journal-title":"J. Immunol."},{"key":"BFnrn2297_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-0-585-37970-8_16","volume":"461","author":"R Yirmiya","year":"1999","unstructured":"Yirmiya, R. et al. Cytokines, \u201cdepression due to a general medical condition\u201d and antidepressant drugs. Adv. Exp. Med. Biol. 461, 283\u2013316 (1999).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnrn2297_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","volume":"27","author":"CL Raison","year":"2006","unstructured":"Raison, C. L., Capuron, L. & Miller, A. H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27, 24\u201331 (2006). An excellent review of the clinical features of cytokine-induced depression and its possible mechanisms.","journal-title":"Trends Immunol."},{"issue":"Suppl 7","key":"BFnrn2297_CR42","first-page":"5","volume":"66","author":"CB Nemeroff","year":"2005","unstructured":"Nemeroff, C. B. & Vale, W. W. The neurobiology of depression: inroads to treatment and new drug discovery. J. Clin. Psychiatry 66, Suppl 7, 5\u201313 (2005).","journal-title":"J. Clin. Psychiatry"},{"key":"BFnrn2297_CR43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","volume":"35","author":"RS Smith","year":"1991","unstructured":"Smith, R. S. The macrophage theory of depression. Med. Hypotheses 35, 298\u2013306 (1991).","journal-title":"Med. Hypotheses"},{"key":"BFnrn2297_CR44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0306-4530(94)00066-J","volume":"20","author":"M Maes","year":"1995","unstructured":"Maes, M., Smith, R. & Scharpe, S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 20, 111\u2013116 (1995).","journal-title":"Psychoneuroendocrinology"},{"key":"BFnrn2297_CR45","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.bbi.2007.01.010","volume":"21","author":"MR Irwin","year":"2007","unstructured":"Irwin, M. R. & Miller, A. H. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav. Immun. 21, 374\u2013383 (2007).","journal-title":"Brain Behav. Immun."},{"key":"BFnrn2297_CR46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/0003-4819-107-2-293","volume":"107","author":"KD Denicoff","year":"1987","unstructured":"Denicoff, K. D. et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann. Intern. Med. 107, 293\u2013300 (1987).","journal-title":"Ann. Intern. Med."},{"key":"BFnrn2297_CR47","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1001\/archinte.1987.00370090055011","volume":"147","author":"PF Renault","year":"1987","unstructured":"Renault, P. F. et al. Psychiatric complications of long-term interferon alfa therapy. Arch. Intern. Med. 147, 1577\u20131580 (1987).","journal-title":"Arch. Intern. Med."},{"key":"BFnrn2297_CR48","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","volume":"26","author":"L Capuron","year":"2002","unstructured":"Capuron, L. et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26, 643\u2013652 (2002).","journal-title":"Neuropsychopharmacology"},{"key":"BFnrn2297_CR49","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1200\/JCO.2000.18.10.2143","volume":"18","author":"L Capuron","year":"2000","unstructured":"Capuron, L., Ravaud, A. & Dantzer, R. Early depressive symptoms in cancer patients receiving interleukin 2 and\/or interferon alfa-2b therapy. J. Clin. Oncol. 18, 2143\u20132151 (2000).","journal-title":"J. Clin. Oncol."},{"key":"BFnrn2297_CR50","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.4088\/JCP.v66n0814","volume":"66","author":"A Constant","year":"2005","unstructured":"Constant, A. et al. Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic\/hypomanic and depressive symptoms. J. Clin. Psychiatry 66, 1050\u20131057 (2005).","journal-title":"J. Clin. Psychiatry"},{"key":"BFnrn2297_CR51","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1056\/NEJM199904293401716","volume":"340","author":"L Capuron","year":"1999","unstructured":"Capuron, L. & Ravaud, A. Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state. N. Engl. J. Med. 340, 1370 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrn2297_CR52","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1176\/appi.ajp.160.7.1342","volume":"160","author":"L Capuron","year":"2003","unstructured":"Capuron, L. et al. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am. J. Psychiatry 160, 1342\u20131345 (2003).","journal-title":"Am. J. Psychiatry"},{"key":"BFnrn2297_CR53","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.psyneuen.2007.03.005","volume":"32","author":"F Frenois","year":"2007","unstructured":"Frenois, F. et al. Lipopolysaccharide induces delayed FosB\/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 32, 516\u2013531 (2007).","journal-title":"Psychoneuroendocrinology"},{"key":"BFnrn2297_CR54","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.pnpbp.2005.03.009","volume":"29","author":"DA Simmons","year":"2005","unstructured":"Simmons, D. A. & Broderick, P. A. Cytokines, stressors, and clinical depression: augmented adaptation responses underlie depression pathogenesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 793\u2013807 (2005).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"BFnrn2297_CR55","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00213-002-1273-1","volume":"165","author":"Z Merali","year":"2003","unstructured":"Merali, Z., Brennan, K., Brau, P. & Anisman, H. Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for \u201cfree chow\u201d and \u201cearned\u201d sucrose intake. Psychopharmacology (Berl.) 165, 413\u2013418 (2003).","journal-title":"Psychopharmacology (Berl.)"},{"key":"BFnrn2297_CR56","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/sj.mp.4000995","volume":"7","author":"L Capuron","year":"2002","unstructured":"Capuron, L. et al. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry 7, 468\u2013473 (2002). A landmark paper demonstrating that repeated activation of the immune system by systemic administration of IL-2 and IFN-\u03b1 to cancer patients induces a drastic fall in plasma tryptophan levels that is positively correlated to the depression scores.","journal-title":"Mol. Psychiatry"},{"key":"BFnrn2297_CR57","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.mp.4001949","volume":"12","author":"HG Ruhe","year":"2007","unstructured":"Ruhe, H. G., Mason, N. S. & Schene, A. H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol. Psychiatry 12, 331\u2013359 (2007).","journal-title":"Mol. Psychiatry"},{"key":"BFnrn2297_CR58","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.2174\/0929867033457179","volume":"10","author":"B Wirleitner","year":"2003","unstructured":"Wirleitner, B., Neurauter, G., Schrocksnadel, K., Frick, B. & Fuchs, D. Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr. Med. Chem. 10, 1581\u20131591 (2003).","journal-title":"Curr. Med. Chem."},{"key":"BFnrn2297_CR59","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0889-1591(02)00014-4","volume":"16","author":"J Lestage","year":"2002","unstructured":"Lestage, J., Verrier, D., Palin, K. & Dantzer, R. The enzyme indoleamine 2, 3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav. Immun. 16, 596\u2013601 (2002).","journal-title":"Brain Behav. Immun."},{"key":"BFnrn2297_CR60","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1086\/431603","volume":"192","author":"M Moreau","year":"2005","unstructured":"Moreau, M. et al. Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2, 3-dioxygenase in mice. J. Infect. Dis. 192, 537\u2013544 (2005).","journal-title":"J. Infect. Dis."},{"key":"BFnrn2297_CR61","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/sj.mp.4002006","volume":"12","author":"N Muller","year":"2007","unstructured":"Muller, N. & Schwarz, M. J. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol. Psychiatry 12, 988\u20131000 (2007).","journal-title":"Mol. Psychiatry"},{"key":"BFnrn2297_CR62","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.neubiorev.2005.03.023","volume":"29","author":"AJ Dunn","year":"2005","unstructured":"Dunn, A. J., Swiergiel, A. H. & de Beaurepaire, R. Cytokines as mediators of depression: what can we learn from animal studies? Neurosci. Biobehav. Rev. 29, 891\u2013909 (2005).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BFnrn2297_CR63","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/sj.npp.1301029","volume":"31","author":"CB Zhu","year":"2006","unstructured":"Zhu, C. B., Blakely, R. D. & Hewlett, W. A. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31, 2121\u20132131 (2006).","journal-title":"Neuropsychopharmacology"},{"key":"BFnrn2297_CR64","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jhep.2005.01.024","volume":"42","author":"W Cai","year":"2005","unstructured":"Cai, W. et al. Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression. J. Hepatol. 42, 880\u2013887 (2005).","journal-title":"J. Hepatol."},{"key":"BFnrn2297_CR65","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1046\/j.1365-2826.2003.01058.x","volume":"15","author":"CM Pariante","year":"2003","unstructured":"Pariante, C. M. Depression, stress and the adrenal axis. J. Neuroendocrinol. 15, 811\u2013812 (2003).","journal-title":"J. Neuroendocrinol."},{"key":"BFnrn2297_CR66","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1126\/science.2443979","volume":"238","author":"F Berkenbosch","year":"1987","unstructured":"Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F. & Besedovsky, H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238, 524\u2013526 (1987).","journal-title":"Science"},{"key":"BFnrn2297_CR67","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1006\/exnr.2002.8022","volume":"178","author":"V Grinevich","year":"2002","unstructured":"Grinevich, V. et al. Hypothalamic pituitary adrenal axis and immune responses to endotoxin in rats with chronic adjuvant-induced arthritis. Exp. Neurol. 178, 112\u2013123 (2002).","journal-title":"Exp. Neurol."},{"key":"BFnrn2297_CR68","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.arr.2005.03.003","volume":"4","author":"DF Swaab","year":"2005","unstructured":"Swaab, D. F., Bao, A. M. & Lucassen, P. J. The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 4, 141\u2013194 (2005).","journal-title":"Ageing Res. Rev."},{"key":"BFnrn2297_CR69","first-page":"46","volume":"4","author":"F Holsboer","year":"2003","unstructured":"Holsboer, F. Corticotropin-releasing hormone modulators and depression. Curr. Opin. Investig. Drugs 4, 46\u201350 (2003).","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"BFnrn2297_CR70","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbi.2006.08.009","volume":"21","author":"TW Pace","year":"2007","unstructured":"Pace, T. W., Hu, F. & Miller, A. H. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. Immun. 21, 9\u201319 (2007).","journal-title":"Brain Behav. Immun."},{"key":"BFnrn2297_CR71","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1176\/appi.ajp.160.9.1554","volume":"160","author":"CL Raison","year":"2003","unstructured":"Raison, C. L. & Miller, A. H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 160, 1554\u20131565 (2003).","journal-title":"Am. J. Psychiatry"},{"key":"BFnrn2297_CR72","doi-asserted-by":"crossref","unstructured":"Fitzgerald, P. B., Laird, A. R., Maller, J. & Daskalakis, Z. J. A meta-analytic study of changes in brain activation in depression. Hum. Brain Mapp. (2007).","DOI":"10.1002\/hbm.20426"},{"key":"BFnrn2297_CR73","doi-asserted-by":"crossref","unstructured":"Capuron, L. et al. Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology (2007).","DOI":"10.1038\/sj.npp.1301362"},{"key":"BFnrn2297_CR74","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.biopsych.2005.03.033","volume":"58","author":"L Capuron","year":"2005","unstructured":"Capuron, L. et al. Anterior cingulate activation and error processing during interferon-alpha treatment. Biol. Psychiatry 58, 190\u2013196 (2005).","journal-title":"Biol. Psychiatry"},{"key":"BFnrn2297_CR75","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.biopsych.2006.04.020","volume":"60","author":"EA Stone","year":"2006","unstructured":"Stone, E. A., Lehmann, M. L., Lin, Y. & Quartermain, D. Depressive behavior in mice due to immune stimulation is accompanied by reduced neural activity in brain regions involved in positively motivated behavior. Biol. Psychiatry 60, 803\u2013811 (2006).","journal-title":"Biol. Psychiatry"},{"key":"BFnrn2297_CR76","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0006-3223(03)00171-9","volume":"54","author":"ML Phillips","year":"2003","unstructured":"Phillips, M. L., Drevets, W. C., Rauch, S. L. & Lane, R. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol. Psychiatry 54, 515\u2013528 (2003).","journal-title":"Biol. Psychiatry"},{"key":"BFnrn2297_CR77","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.neuroscience.2007.01.067","volume":"146","author":"CA Lowry","year":"2007","unstructured":"Lowry, C. A. et al. Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior. Neuroscience 146, 756\u2013772 (2007).","journal-title":"Neuroscience"},{"key":"BFnrn2297_CR78","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrn894","volume":"3","author":"AD Craig","year":"2002","unstructured":"Craig, A. D. How do you feel? Interoception: the sense of the physiological condition of the body. Nature Rev. Neurosci. 3, 655\u2013666 (2002).","journal-title":"Nature Rev. Neurosci."},{"issue":"Suppl 3","key":"BFnrn2297_CR79","first-page":"64","volume":"31","author":"N Frasure-Smith","year":"2006","unstructured":"Frasure-Smith, N. & Lesperance, F. Depression and coronary artery disease. Herz 31, Suppl 3, 64\u201368 (2006).","journal-title":"Herz"},{"key":"BFnrn2297_CR80","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","volume":"367","author":"S Tyring","year":"2006","unstructured":"Tyring, S. et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367, 29\u201335 (2006).","journal-title":"Lancet"},{"key":"BFnrn2297_CR81","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/sj.mp.4001805","volume":"11","author":"N Muller","year":"2006","unstructured":"Muller, N. et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry 11, 680\u2013684 (2006).","journal-title":"Mol. Psychiatry"},{"key":"BFnrn2297_CR82","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.exger.2007.01.011","volume":"42","author":"AH van den Biggelaar","year":"2007","unstructured":"van den Biggelaar, A. H. et al. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp. Gerontol. 42, 693\u2013701 (2007).","journal-title":"Exp. Gerontol."},{"key":"BFnrn2297_CR83","unstructured":"Godbout, J. P. et al. Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology (in the press)."},{"key":"BFnrn2297_CR84","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1144400","volume":"317","author":"RD Airan","year":"2007","unstructured":"Airan, R. D. et al. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 317, 819\u2013823 (2007).","journal-title":"Science"},{"key":"BFnrn2297_CR85","doi-asserted-by":"publisher","first-page":"6628","DOI":"10.1074\/jbc.275.9.6628","volume":"275","author":"H Sheng","year":"2000","unstructured":"Sheng, H. et al. Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J. Biol. Chem. 275, 6628\u20136635 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2297_CR86","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1006\/cyto.1999.0661","volume":"12","author":"TA Babcock","year":"2000","unstructured":"Babcock, T. A. & Carlin, J. M. Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells. Cytokine 12, 588\u2013594 (2000).","journal-title":"Cytokine"},{"key":"BFnrn2297_CR87","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/jnnp.2004.054635","volume":"76","author":"RJ Siegert","year":"2005","unstructured":"Siegert, R. J. & Abernethy, D. A. Depression in multiple sclerosis: a review. J. Neurol. Neurosurg. Psychiatry 76, 469\u2013475 (2005).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrn2297_CR88","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0165-5728(03)00075-4","volume":"137","author":"Y Pollak","year":"2003","unstructured":"Pollak, Y., Ovadia, H., Orion, E., Weidenfeld, J. & Yirmiya, R. The EAE-associated behavioral syndrome: I. Temporal correlation with inflammatory mediators. J. Neuroimmunol. 137, 94\u201399 (2003).","journal-title":"J. Neuroimmunol."},{"key":"BFnrn2297_CR89","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0165-5728(03)00073-0","volume":"137","author":"Y Pollak","year":"2003","unstructured":"Pollak, Y., Ovadia, H., Orion, E. & Yirmiya, R. The EAE-associated behavioral syndrome: II. Modulation by anti-inflammatory treatments. J. Neuroimmunol. 137, 100\u2013108 (2003).","journal-title":"J. Neuroimmunol."},{"key":"BFnrn2297_CR90","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nm1202","volume":"11","author":"EJ McMahon","year":"2005","unstructured":"McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H. & Miller, S. D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nature Med. 11, 335\u2013339 (2005).","journal-title":"Nature Med."},{"key":"BFnrn2297_CR91","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1196\/annals.1394.023","volume":"1103","author":"SD Miller","year":"2007","unstructured":"Miller, S. D., McMahon, E. J., Schreiner, B. & Bailey, S. L. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci. 1103, 179\u2013191 (2007).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrn2297_CR92","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1523\/JNEUROSCI.4560-06.2007","volume":"27","author":"DR Johnson","year":"2007","unstructured":"Johnson, D. R., O'Connor, J. C., Hartman, M. E., Tapping, R. I. & Freund, G. G. Acute hypoxia activates the neuroimmune system, which diabetes exacerbates. J. Neurosci. 27, 1161\u20131166 (2007).","journal-title":"J. Neurosci."},{"key":"BFnrn2297_CR93","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.4088\/JCP.v64n1009","volume":"64","author":"MM Ohayon","year":"2003","unstructured":"Ohayon, M. M. The effects of breathing-related sleep disorders on mood disturbances in the general population. J. Clin. Psychiatry 64, 1195\u20131200; quiz, 1274\u20131276 (2003).","journal-title":"J. Clin. Psychiatry"},{"key":"BFnrn2297_CR94","first-page":"115","volume":"3","author":"S Borson","year":"1998","unstructured":"Borson, S., Claypoole, K. & McDonald, G. J. Depression and chronic obstructive pulmonary disease: treatment trials. Semin. Clin. Neuropsychiatry 3, 115\u2013130 (1998).","journal-title":"Semin. Clin. Neuropsychiatry"},{"key":"BFnrn2297_CR95","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.coph.2003.10.006","volume":"4","author":"R Schwarcz","year":"2004","unstructured":"Schwarcz, R. The kynurenine pathway of tryptophan degradation as a drug target. Curr. Opin. Pharmacol. 4, 12\u201317 (2004).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnrn2297_CR96","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0306-4522(02)00030-1","volume":"112","author":"MI Combrinck","year":"2002","unstructured":"Combrinck, M. I., Perry, V. H. & Cunningham, C. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 112, 7\u201311 (2002).","journal-title":"Neuroscience"},{"key":"BFnrn2297_CR97","doi-asserted-by":"publisher","first-page":"9275","DOI":"10.1523\/JNEUROSCI.2614-05.2005","volume":"25","author":"C Cunningham","year":"2005","unstructured":"Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K. & Perry, V. H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25, 9275\u20139284 (2005).","journal-title":"J. Neurosci."},{"key":"BFnrn2297_CR98","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1096\/fj.05-3776fje","volume":"19","author":"JP Godbout","year":"2005","unstructured":"Godbout, J. P. et al. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. Faseb J. 19, 1329\u20131331 (2005).","journal-title":"Faseb J."},{"key":"BFnrn2297_CR99","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.imbio.2006.05.007","volume":"211","author":"K Schroder","year":"2006","unstructured":"Schroder, K., Sweet, M. J. & Hume, D. A. Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology 211, 511\u2013524 (2006).","journal-title":"Immunobiology"},{"key":"BFnrn2297_CR100","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nri2015","volume":"7","author":"VH Perry","year":"2007","unstructured":"Perry, V. H., Cunningham, C. & Holmes, C. Systemic infections and inflammation affect chronic neurodegeneration. Nature Rev. Immunol. 7, 161\u2013167 (2007). A presentation of the concept of priming of the microglial compartment during chronic brain inflammation and its role in the exaggerated response to systemic infections.","journal-title":"Nature Rev. Immunol."},{"key":"BFnrn2297_CR101","doi-asserted-by":"crossref","unstructured":"Stichel, C. C. & Luebbert, H. Inflammatory processes in the aging mouse brain: participation of dendritic cells and T-cells. Neurobiol. Aging (2006).","DOI":"10.1016\/j.neurobiolaging.2006.07.022"},{"key":"BFnrn2297_CR102","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1523\/JNEUROSCI.20-01-00401.2000","volume":"20","author":"AJ Silverman","year":"2000","unstructured":"Silverman, A. J., Sutherland, A. K., Wilhelm, M. & Silver, R. Mast cells migrate from blood to brain. J. Neurosci. 20, 401\u2013408 (2000).","journal-title":"J. Neurosci."},{"key":"BFnrn2297_CR103","doi-asserted-by":"crossref","unstructured":"of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain Behav. Immun. 12, 212\u2013229 (1998).","DOI":"10.1006\/brbi.1998.0524"},{"key":"BFnrn2297_CR104","doi-asserted-by":"publisher","first-page":"6811","DOI":"10.1523\/JNEUROSCI.20-18-06811.2000","volume":"20","author":"E Vereker","year":"2000","unstructured":"Vereker, E., O'Donnell, E. & Lynch, M. A. The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J. Neurosci. 20, 6811\u20136819 (2000).","journal-title":"J. Neurosci."},{"key":"BFnrn2297_CR105","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1207\/s15516709cog1202_4","volume":"12","author":"J Sweller","year":"1988","unstructured":"Sweller, J. Cognitive load during problem solving: effects on learning. Cognitive Sci. 12, 257\u2013285 (1988).","journal-title":"Cognitive Sci."},{"key":"BFnrn2297_CR106","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.nbd.2004.07.012","volume":"17","author":"D Blum","year":"2004","unstructured":"Blum, D., Chtarto, A., Tenenbaum, L., Brotchi, J. & Levivier, M. Clinical potential of minocycline for neurodegenerative disorders. Neurobiol. Dis. 17, 359\u2013366 (2004).","journal-title":"Neurobiol. Dis."}],"container-title":["Nature Reviews Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrn2297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrn2297","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrn2297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T15:27:47Z","timestamp":1650036467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrn2297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["BFnrn2297"],"URL":"https:\/\/doi.org\/10.1038\/nrn2297","relation":{},"ISSN":["1471-003X","1471-0048"],"issn-type":[{"value":"1471-003X","type":"print"},{"value":"1471-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}